Here’s what you should know:
1. Perceptive Advisors led the financing round, serving as the exclusive investor.
2. Landos is a pharmaceutical pipeline developing treatments for autoimmune diseases, specifically for Crohn’s disease and ulcerative colitis.
3. The funding will be used to advance the development of BT-11, specifically to advance the product through its initial phase I clinical testing.
More articles on gastroenterology:
GI leader to know: Dr. Daryl M. McClendon of Alaska Digestive and Liver Disease Clinic
12 statistics on gastroenterologist salary — $357k is median
Penn State College of Medicine taps Dr. Thomas Ma for chairmanship — 4 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
